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Abstract 
Spectral Cross-correlation is introduced as a methodology to identify the presence and 
subcellular distribution of nanoparticles in cells. Raman microscopy is employed to 
spectroscopically image biological cells previously exposed to polystyrene nanoparticles, as a 
model for the study of nano-bio interactions. The limitations of previously deployed strategies of 
K-means clustering analysis and principal component analysis are discussed and a novel 
methodology of Spectral Cross Correlation Analysis is introduced and compared with the 
performance of Classical Least Squares Analysis, in both unsupervised and supervised modes. 
The previous study demonstrated the feasibility of using Raman spectroscopy to map cells and 
identify polystyrene nanoparticles in a lipid rich environment, which is suggestive of the 
membrane rich endoplasmic reticulum. However, short comings in identification of all 
nanoparticle signatures in the cell using K-means clustering are apparent, as highlighted by 
principal component analysis of the identified clusters which demonstrates that K-means 
clustering does not identify all regions where spectral signatures of the nanoparticles are evident. 
Thus, two more sophisticated analytical approaches to the extraction of the nanoparticle 
signatures from the Raman spectral data sets, namely classical least squares analysis and cross 
correlation analysis, were employed and are demonstrated to improve the identification of 
spectroscopic signatures characteristic of polystyrene nanoparticles in a cellular environment. 
Additionally, to investigate the local biochemical environment in which the nanoparticles are 
trafficked, a pure spectrum of 3-sn-phosphatidyl ethanolamine was cross correlated against the 
Raman data set, further suggesting the particles are indeed localized in a lipid rich environment. 
Furthermore, to demonstrate the robustness and versatility of the analysis method, a  spectrum of 
pure RNA was used to demonstrate that a differentiation could be made between DNA of the 
nucleus and RNA of the nucleolus using the supervised spectral cross-correlation technique.     
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Introduction  
Nanotechnology is set to become the first trillion dollar industry in history, with predicted 
benefits which span a wide range of fields, including applications in site specific delivery of 
drugs in humans, to antimicrobial paint coatings and textile finishing, to advances in the 
electronics industry 1–6. However, there are caveats associated with deploying these 
nanotechnologies which must be addressed before true realistic applications can be widely 
accepted and adopted as the norm.  
 It is widely known that nanomaterials, more specifically nanoparticles, possess a range of 
unique characteristics which in some ways dictate their usefulness and applicability in fields 
such as medical science. Properties such as increased surface to mass ratio result in an increased 
reactivity and associated novel optical properties result in new possibilities in diagnostic and 
theranostic imaging and delivery7,8, while novel semi-conductor properties are applicable to the 
electronics industry9. However, these properties also potentially have negative implications, most 
importantly in terms of the potential impact of nanoparticle exposure on human health and the 
environment. Nanoparticles have been demonstrated to be taken up by cells in vitro and to elicit 
a toxic response while many reports exist of adverse toxic effects in vivo10–15. 
One of the challenges facing the nanotoxicology community is the detection and 
monitoring of the interaction mechanisms of nanoparticles in cells16,17. Currently, fluorescent 
microscopy is the most widely used and accessible method to study nanoparticle uptake and 
trafficking18–23. Necessarily, however, it relies on the use of inherently fluorescent or labelled 
compounds for visualization and monitoring of nanoparticles inside cells. Most nanoparticles are 
not intrinsically fluorescent, however, and it has been recently demonstrated that fluorescent 
labels can be labile, and that the observation and distribution of intracellular fluorescence 
following nanoparticle exposure is not necessarily representative of the presence or distribution 
of nanoparticles in the cell24. While it is also possible to study the dynamics of nanoparticle 
trafficking using label free optical microscopic techniques such as dark field and differential 
interference contrast (DIC) microscopy, the techniques are mainly applicable to metal particles 
such as gold and silver.25 Transmission electron microscopy (TEM) provides an additional 
method by which nanoparticles can be visualised in a cellular environment26–28. The high lateral 
resolution obtainable with TEM renders it an ideal method for visualising sub cellular organelles 
and uptake and interaction of nanoparticles. However, significant sample processing (fixing and 
ultramicrotoming) is required and only particles with sufficient electronic contrast to the cellular 
environment can be visualised28,29  
Thus, a label-free technique is required which can ideally unambiguously identify the 
presence of the nanoparticles in the cells, their sub-cellular location, and their overall effect on 
the cellular metabolism. Raman spectroscopy is one such method which may provide an alternate 
to traditional approaches for studying the nanoparticle-biological interface. The technique 
provides not only a label free method to visualize how the nanoparticle behaves in a biological 
environment, but offers the potential to identify the local environment and simultaneously 
analyse the associated metabolic changes. To do this, one must combine Raman spectroscopy 
with analytical data mining approaches to extract the signatures associated with the nanoparticles 
but also to probe the environment the particles are localized in, and to correlate the exposure and 
subcellular interaction mechanisms with the metabolic changes.   
 Previous studies have indicated the potential of Raman as a label free method for 
studying biological processes. Examples include novel approaches for cervical cancer 
diagnostics30, to investigating the effects following exposure to human papilloma virus (HPV) 
infection31, the effects of chemotherapeutic anticancer agents in cells32,33, live cell 
analysis34,35and the toxic responses to single walled carbon nano-tubes (SWCNT), to name but a 
few36.     
Surface enhanced Raman scattering (SERS) is also a potential method to study the 
intracellular dynamics of nanoparticle trafficking and compartmentalisation37,38. However, only 
certain types of nanoparticle, such as gold and silver particles and nanoaggregates have the 
potential to generate SERS spectra, thus limiting the technique to the study of only a certain type 
of nanoparticles. Additionally the surface enhancement process and molecular specificity of the 
technique are not fully understood, which may lead to ambiguity in the understanding of cellular 
trafficking.  
A more recent study indicated the ability of Raman spectroscopy to detect the presence of 
intracellular polystyrene nanoparticles39. Polystyrene was chosen as a model nanoparticle for the 
study as it is commercially available and regularly employed as a standard in nanotoxicology 
(particularly as a positive control in its aminated form). Furthermore, the conjugated styrene ring 
makes it a relatively strong Raman scatterer. However, while the identification is somewhat 
straight forward, the presence of overlapping peaks in both the polystyrene and cellular spectra 
(e.g. both cellular and polystyrene spectra exhibit a strong symmetric ring breathing peak at 
~1004cm-1) presents a challenging system with which to validate the effectivity of the 
experimental and data analysis techniques. K-means clustering analysis (KMCA) analysis was 
used to differentiate regions of the cell as well as to identify and localise the nanoparticles. 
Analysis of the local cellular environment of the detected nanoparticles was performed via a 
comparison between loadings obtained from principal component analysis (PCA) and pure 
spectra of lipids and polystyrene nanoparticles. However, when the data was analyzed using 
PCA, it was noted that the clusters detected using KMCA failed to identify all regions which 
contained the spectral fingerprint corresponding to polystyrene in a biological environment. 
Furthermore, the average spectra of the cluster identified by KMCA, while containing features 
clearly characteristic of polystyrene, also contained spectral features of the neighbouring cellular 
environment. Analysis of the loading of the principal components provided a clearer 
differentiation of the nanoparticle contributions from the local cellular environment, but neither 
unsupervised technique provided an unambiguous localisation of the target species 39. 
Other multivariate analytical approaches have also been applied in the field of Raman 
microspectroscopy of cells. In addition to KMCA, other clustering methods such as Fuzzy C 
means clustering (FCM) and hierarchal cluster analysis (HCA) have been used to separate the 
cellular Raman data into clusters and subsequently reshape the data into images40,41. However, as 
highlighted by Headegaad et al., these approaches have their own limitations. In particular 
boundaries between sub-cellular features can often result in the addition of extra clusters with 
mixed spectral signatures. This addition can be overcome by increasing the number of clusters; 
however, this in turn can result in added complexity to interpretation and inaccuracies in regional 
seperation. Additionally, the reproducibility of these methods can also be questioned as the 
starting point for the centroid based KMCA and FCM is subjective40.     
PCA and vertex component analysis (VCA) have also been used to separate out distinct 
regions of the cell. With regards to PCA, separation is based on the variances between the 
spectra in the data set, the majority of the variance being described by the first three principal 
components40. Thus, the score values can be used to construct a composite image of the cell in 
which the biochemical contributions of each component are described by the corresponding 
loadings plot. Unlike KMCA and FCM, PCA identifies quite accurately the boundaries between 
each feature. However, the images generated suffer from inferior contrast and in some instances 
interpretation may be difficult as biochemical features may be spread across different loadings.   
VCA is another method which has been used for similar analytical purposes. In brief, 
VCA computes a linear combination of supposed pure component spectra which are termed 
endmember spectra. As described in Miljkovic et al., the endmember spectra are acquired under 
the assumption that the most extreme data points in the dataset are representative of pure 
component spectra41. However, it has been pointed out that the endmembers generated are not 
truly representative of the pure component they describe in the data set and can often contain a 
mixture of biochemical constituents i.e. DNA and proteins42. While this is representative of the 
true nature of nucleic acids in-situ, it could lead to inaccuracies in interpretation.  
The work presented here demonstrates the potential of a Spectral Cross Correlation 
Analysis (SCCA) for the analysis of Raman spectral datasets. The method is applied to the 
dataset of Dorney et al. 39, of polystyrene nanoparticles in A549 lung adenocarcinoma cells, and 
is thus compared with previous analyses by KMCA and PCA. The performance of SCCA is also 
compared to that of classical least squares analysis (CLSA), performed both in a supervised and 
unsupervised manner, which allows for a direct comparison between both approaches. SCCA 
utilises the spectrum of the target chemical component and cross correlates the spectrum with 
that of the complete Raman spectral dataset. The quantitative performance is demonstrated using 
simulated datasets and the potential is demonstrated by mapping the spatial profile of the 
polystyrene nanoparticles in the cells as well as other biochemical components of the cell, (RNA 
and lipids).  
Experimental 
  
Sample Preparation for Raman Imaging 
 
A549 Cells were seeded at a density of 4 x 104 cells onto calcium fluoride (CaF2) windows 
(Crystran Ltd., UK) for confocal Raman imaging. The cells were incubated for 24 hrs in 
Dulbecco’s Modified Eagle’s Medium (DMEM F12), supplemented with 10% foetal calf serum 
(FCS) and 1% L-Glutamine at 37°C, 5% CO2.  Following cell adherence, 2 mLs of medium 
containing 1x 1012 nanoparticles per mL were added to the cells. The cells and nanoparticles 
were incubated for 24hrs at 37°C and 5% CO2.  Following nanoparticle exposure, the cells were 
washed in warm PBS three times and fixed for 10mins in 10% buffered formalin. After fixation, 
the cells were washed to remove any trace of fixative and kept in NaCl solution prior to imaging. 
Component spectra used in SCCA were generated as described in Bonnier and Byrne 201243. For 
polystyrene nanoparticle spectra, nanoparticle suspension was added drop-wise to a CaF2 
window and allowed to air dry prior to Raman acquisition. RNA from baker’s yeast 
(saccharomyces cerevisiae) was added to water and subsequently deposited on a CaF2 window 
and allowed to air dry. 3-sn-phosphatidyl ethanolamine was dispersed in chloroform and 
deposited on CaF2 windows.  
 
Confocal Raman Spectroscopic Imaging 
Confocal Raman Spectroscopic Imaging was performed using a Horiba Yobin-Yvon LabRAM 
HR800 spectrometer with a 785nm, 300mmW diode laser as source and a Peltier cooled 16-bit 
CCD. A 100X, N.A. 1.2, (LUMplanF1, Olympus) water immersion objective was used for all 
cellular measurements. The confocal pin hole of the system was set to 100µm, the recommended 
setting for confocal operation, to allow optical sectioning of the sample. A 300 lines per mm 
spectroscopic grating, providing a dispersion of ~1.5cm-1 per pixel, was used and the system was 
pre-calibrated to the spectral line at 520.7cm-1 of silicon. Using an automated programmable 
stage, Raman spectra of the cell were acquired with a 0.75µm step size over a 29*39 pixel area 
which encompassed the nuclear, perinuclear and cytoplasmic regions of the cell. 
Data Pre-Processing and Preparation  
In order to prepare the data for analysis, a number of steps were taken to ensure the spectra in the 
map were of a high enough quality to give accurate results. For CLSA, all data pre-processing 
was carried out using Labspec 5 software which comes as standard on the Raman instrument. 
Firstly, a background spectrum which constituted the contribution of the CaF2 substrate and 
water in the imaging medium was subtracted from each spectrum in the mapped data set. 
Following subtraction of the background spectrum, a Savitsky-Golay smoothing filter (5th order, 
7 points), available on the software, was used to lightly smooth the data. The data was then 
baseline corrected using a nodal point baseline correction using the minimum amount of points 
possible to ensure minimal alteration of the acquired data. Normalization was carried out 
automatically by the software during CLSA. 
 Data was prepared in a similar fashion for SCCA. However, the pre-processing was 
carried out in Matlab (Mathworks,USA) using previously published protocols for data 
processing39. As outlined above, a background spectrum was subtracted from the Raman data set 
to remove the substrate and immersion medium contributions. A Savitsky-Golay smoothing filter 
(5th order, 7 points) was applied to the data and a nodal point baseline correction was used to 
baseline the data using a minimum amount of reference points to do so. Preparation of 
component spectra for SCCA was done in the same manner for polystyrene, RNA and lipids.    
 
Classical Least Squares Analysis 
CLSA was carried out using Labspec 5 software which comes as standard on the Raman 
spectrometer software. The analysis method is based on a fit of a linear combination of reference 
component spectra to the spectra contained in the raw spectral map. This is described by 
Equation 1, for the case where three reference component spectra are used. S is the sum of the 
linear contribution of the reference components (A, B, C), and x, y, z are the respective 
weightings or scores necessary for the weighted sum of the reference component spectra to 
match the raw data.  
S = [x*A] +[y*B] + [z*C]  Equation 1 
Using the software, there are two different ways to obtain the reference component spectra. The 
first way is to obtain a pure spectral reference from a compound or compounds which can then 
be fitted according to Equation 1. The second method uses a factor analysis algorithm to generate 
the component spectra, the weighted sum of which is compared to the Raman spectral data set. 
Using the latter of the two methods, Zavaleta et al demonstrated the power of the technique to 
quantify quantum dot accumulation in an in-vivo mouse model and to separate out the different 
spectral contributions from complex SERS signals in the same data set44. In a similar and 
different way, both approaches to CLSA are explored to extract spectra which contain 
polystyrene nanoparticles and define other biochemical regions such as the RNA and lipid rich 
environments. The relative contributions of the different components are defined by the 
weighting factors (x, y, z….).  
 
Spectral Cross Correlation Analysis 
For SCCA, reference spectra from polystyrene, phosphatidyl-ethanolamine and RNA (Figure 
1A) were used to screen the Raman spectral data set. All SCCA was carried out using Matlab 
(Mathworks, USA) using the “crosscorr” function available in the signal processing toolbox. 
Equation 2 describes the cross correlation between two data series, where C(x) is the correlation 
function, S(τ) is the Raman spectrum in the data set to be tested and A(x+τ) is the reference 
spectrum i.e. polystyrene, lipid or RNA. The function integrates the product of the two data 
series (spectra) at each point as they are shifted relative to each other along the x axis (wave 
number). The magnitude of the correlation quantifies the relative contribution of the component 
spectrum at that point in the cell, and an exact correlation occurs when the spectra are exactly 
matched (auto-correlation). In this way, it is possible to screen the map or spectra in the map and, 
based on the cross correlation function, cluster different biochemical regions of the cell based on 
the relative contributions of the reference spectrum used.     
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Simulated Data  
Simulated data sets were used to test the robustness and sensitivity of both CLSA and SCCA in 
their ability to detect spectral contributions due to polystyrene, RNA and lipid in a biological 
environment. To generate the simulated data sets, a cellular spectrum was used as a template to 
which varied amounts of component spectrum were added. Keeping the cellular spectrum 
constant, a series of 38 simulated spectra of ratios 1:1 to 1:10-4, cellular: component Raman 
spectra for polystyrene, RNA and lipid were generated (Figure 1A). An example of the simulated 
data set for polystyrene is shown in Figure 1B, which shows the addition of the first 8 spectral 
dilutions to the constant cellular spectrum. Using these simulated datasets, it was possible to 
explore how each data mining approach performs when testing experimental data and thus 
facilitate accurate interpretation of the data sets.   
 
 
Figure 1. (A) Component spectra of nano-polystyrene (dotted line), 3-sn-phosphatidyl 
ethanolamine (dashed line) and isolated RNA (solid line), offset for clarity. (B) Shows an 
example of the first eight simulated spectra for polystyrene in cells, offset for clarity. Each 
spectrum consists of a constant cellular spectrum with a varied concentration of polystyrene 
added to it, with decreasing polystyrene concentration from top to bottom. Simulated data sets 
generated in this way were then analysed by CLSA and SCCA. 
   
Results  
 
Simulated Data – Unsupervised CLSA 
 
CLSA can be carried out in two different ways, either by generating spectral models using a 
factor analysis algorithm (unsupervised), or by manually inputting the component spectra 
(supervised). The data in Figure 2 shows the results using the factor analysis generated models 
for simulated data sets generated based on cellular/polystyrene, RNA and lipid spectra (Figure 1 
B). In each instance, the score recorded form CLSA for each spectrum is plotted against the 
component concentration added to the data set. In all cases, the extracted CLSA scores 
accurately represent the true component ratios over the concentration range, represented by the 
solid line. The results depart from nonlinearity a cellular:component ratio of ~1:0.1, after which 
the CLSA weightings no longer accurately reflect the correct component weighting, although the 
presence of the component can still be identified in ratios as low as 1:0.03.  
Figure 2. CLSA of simulated spectral data sets of nano
graph, the score from the CLSA
added to a constant cellular spectrum (points on each graph). The solid black line represents the 
ideal response which gives an indi
 
 
 
Single Cell Data – Unsupervised
 
In order to further test the ability of CLS
located inside a single cell Raman map, an initial factor analysis algorithm was applied to the 
data set to generate 7 model spectra to be used in the CLSA
to compute the scores from the Raman data set (Fig
-polystyrene, RNA and lipid. In each 
 is plotted against the concentration of component spectrum 
cation of the quantitative nature of the technique.  
 CLSA  
A to identify intracellular polystyrene
. These model spectra 
ure 3A). It is then possible
 
 
 nanoparticles 
were then used 
 to segment the 
cell into different distributions based on specific spectral differences as shown in Figure 3B. The 
spectral profile of each model contribution can be visualized individually showing the percentage 
contribution at each pixel (Figure 3C-F). A more detailed look at the model spectra generated 
and corresponding cellular distribution can be seen in Figure 4A-G.  
 The CLSA map shows a different spatial distribution of each model in the Raman 
spectral data set. Although in all cases, the model spectra show strong contributions of the 
cellular environment, they are differentiated by contributions from distinct components. Model 1 
(Figure 4A) shows characteristic peaks corresponding to those seen in pure polystyrene spectra 
(see Figure 1A). Therefore, the pixel distribution of model 1 is deemed to show the localisation 
of the polystyrene nanoparticles, indicating a perinuclear distribution in the cell, consistent with 
the K-means cluster analysis of Dorney et al39. Other models show a different distribution in the 
cell. Model 6 shows a distribution which visually corresponds to the nucleolus of the cell (Figure 
4B), whereas model 3 surrounds the nucleoli and is identified as the nucleus of the cell (Figure 
4E). This shows the ability of CLSA to differentiate the biochemical regions of the cell 
containing RNA and DNA. Other models such as model 4 (Figure 4C) and model7 (Figure 4F) 
show a distinct distribution surrounding the nucleus, which may correspond to perinuclear 
organelles such as the endoplasmic reticulum or the Golgi apparatus which are lipid rich regions 
of the cell.  
Figure 3: Clustering of spectra identified by unsupervised CLS
from the analysis protocol and used to generate the clustered map shown 
(C-I) shows the distribution of each model created in the map. Of particular note
model 6(D) and model 7(H) have strong contributions of
lipid respectively. The spectra in (A) are col
the exception of Model 6 which corresponds to the white image in (D).
       
A. (A) Spectral models generated 
in (B). The right panel 
 the spectra of polystyrene, RNA and 
our coded and correspond to images (B 
 
 
, model 1(C), 
– F), with 
Figure 4: A closer look at the generated model spectra created 
between pixels corresponds to a percentage contribution from each particular model. In some 
instances a pixel may contain 50% of one model and
somewhat by the intensity of the pixel, 
 
 
Simulated Data - Supervised CLS
Unsupervised CLSA is clearly a powerful technique to analyse the subcellular
identify the presence and distribution of nanoparticles. However, it should be noted that the 
technique does not yield pure spectra of the components (compare for example Figure 4A with 
by CLSA (A-
 50% of another, which is highlighted 
although this is visually subjective.     
A  
 
G). The overlap 
 structure and to 
the pure spectrum of polystyrene in Figure 1A), and the respective models are mixtures of 
spectral signatures of the components and the background cellular spectrum. A secondary 
approach to CLSA which provides a more supervised approach was therefore also tested. In a 
similar way, the simulated datasets were used to assess the technique prior to testing the real 
Raman cellular map.  
The simulated data sets generated to test the unsupervised factor analysis algorithm model 
generation approach to CLSA were used again to test the supervised approach which uses 
component spectra of polystyrene, RNA and lipid as the model spectra to generate scores for 
each spectrum in the data set.  In the simulated data shown in Figure 5, it is observed that it is 
possible to identify a trend similar to that seen in Figure 2 for the unsupervised CLSA. For RNA 
and lipid, the trend matches well the predicted response for concentrations as low as 1:0.1, 
whereupon it deviates from linearity, falling to zero at a ratio of~1:0.03. However, for 
polystyrene, although the trends are similar, the results are deviate from the predicted response 
much earlier than the unsupervised CLSA. This indicates that the identification of the 
components using a supervised CLSA approach may not be as accurate as the model generation 
approach shown in Figure 3.  Thus, to test this prediction and for comparison, supervised CLSA 
was carried out on the same cellular data set using polystyrene, RNA and lipid spectra as the 
cellular components used to generate the scores for CLSA.     
 
Figure 5.  Supervised CLSA of simulated spectral data sets of nano
In each graph, either the pure spectrum of polystyrene, RNA or lipid was used to calculate the 
CLSA score. This score was then plotted against the concentra
spectrum: cellular spectrum used to generate the simulated data set
 
 
 
Single Cell Data - Supervised CLS
In order to compare the different CLS
using three pure component spectra
to use these spectra to generate the CLS
-polystyrene, RNA and lipid. 
tion ratio of pure component 
.  
A  
A approaches, the cellular Raman data set was screened 
 individually, nano-polystyrene, RNA and lipid. The aim was 
A scores and thus identify regions of the cell which 
 
correspond to each spectrum, identifying different regions of the cell based on their biochemical 
composition and also where the nanoparticles were situated.  
 The spectra and corresponding score maps are shown in Figure 6 A – C.  Figure 6A 
shows a spectrum of polystyrene which was used to screen the map and corresponding visual 
image of the distribution of nano-polystyrene in the cell. In the image, it is observed that the 
polystyrene is present in every spectrum in the cell, albeit in differing amounts based on the pixel 
intensity at each point. This is not consistent with the model generated CLSA above or with 
previously published data which show the polystyrene to be localised in clusters surrounding the 
nucleus39. However, the regions of high intensity most likely correspond to the areas which 
contain the nanoparticles.  
 Similarly this method for assessing the distribution of RNA and lipids in the cell does not 
quite reproduce the results observed above for CLSA using the unsupervised factor analysis 
algorithm. Again, it is observed that the distribution of lipid and RNA is throughout the Raman 
map of the cell, which, while more plausible for lipids, does not make biological sense for the 
RNA. Therefore, again it must be concluded that the supervised CLSA approach is prone to 
error, although it is still possible to compare regions of high intensity to the output of the 
unsupervised CLSA images above. An arbitrary threshold can be applied to the dataset, as is 
shown for the three component spectra in the right hand panels of Figure 6A-C. Using this 
method, the spatial distributions of the components matches well that of the unsupervised CLSA. 
However this threshold is ambiguous and it is not possible to say from the simulated data at what 
value an accurate representation of the biochemical distribution in the cell is achieved.     
 
 Figure 6: Supervised CLSA using component spectra of polystyrene (A)
phosphatidyl ethanolamine. The spectrum of each pure 
graph, with the corresponding to non
thresholded data shown on the right.  
 
 
 
, RNA (B) and (C) 3
component is shown on the left of the 
-thresholded data shown in the middle and arbitrarily 
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 Simulated data –Spectral Cross Correlation Analysis 
The observations in Figure 6 that supervised CLSA contained a high level of error in the Raman 
images prompted a search for an alternate supervised approach to screening Raman data sets 
which could be used to unambiguously identify regions of the cell which correspond to the pure 
component spectrum of interest chosen, be that polystyrene, RNA, lipid or any other spectral 
signature which may be of interest. A novel technique was thus investigated for the analysis of 
Raman maps, which uses cross correlation as a method to investigate the presence or absence of 
a component in a complex Raman data set in a supervised manner. Thus, SCCA was used to 
screen the same simulated and real data sets for the presence of polystyrene, RNA and lipid for 
comparison which both methods of CLSA.       
Spectral cross correlation analysis (SCCA) was initially investigated using the same simulated 
data sets that were used to investigate both CLSA approaches. Similar to the supervised CLSA 
approach, pure component spectra were used to screen each data set for the presence of each in 
their respective simulated data set. Figure 7 compares the results of the simulated SCCA for each 
of the different components polystyrene, lipid and RNA. In all cases, a correlation of the SCCA 
co-efficient and the true concentration ratios is observed, but to varying degrees of accuracy. 
For polystyrene, a minimum correlation coefficient value of ~ 0.3 is reached at a 
concentration ratio of cellular: polystyrene spectrum of ~ 1:0.1. This indicates that at this 
concentration ratio, the presence of the polystyrene spectral fingerprint cannot be distinguished 
from the cellular spectrum. Thus, for the practical implications of screening a cell for polystyrene 
nanoparticles, correlation coefficient values at or below 0.3 represent the cellular peaks which 
overlap with characteristic polystyrene peaks and thus values below this are deemed not to be 
nanoparticles. This hypothesis was tested using a blank Raman map which contained no 
polystyrene data in (data not shown) and a value of correlation of 0.3125 was determined, which 
is close to the predicted value in the simulated data sets. This indicates the need to threshold 
cellular data in order to identify polystyrene nanoparticles in the cell. 
 A similar performance was observed for both RNA and lipid simulated data sets, where 
an initial decrease in the correlation coefficient was observed in relation to concentration ratio of 
pure component: cell spectrum. Again a minimum baseline correlation coefficient was observed 
for both RNA and lipid simulated SCCA data. Notably, however, this value was different, in 
both cases higher, than that observed for polystyrene, possibly due to an increased overlap of 
Raman bands present in the lipid and RNA spectra with cellular Raman bands in comparison to 
the polystyrene spectrum. In the case of the lipid contribution, the correlation with the predicted 
response is quantitatively poor even at ratios above 1:0.1. However, this can possibly be 
explained by lipid contributions already present in the cellular spectrum and/or the relatively 
broad lipid bands present in the lipid spectrum used. 
 The next step was to investigate the performance of SCCA in a real Raman data set of the 
cell. Thus the previous map was screened in a supervised manner to investigate if nano-
polystyrene could be identified in the Raman map.  Additionally, the lipid spectrum was used to 
see if the local cell environment could be investigated. Also, as used in the above supervised 
CLSA, RNA was used to see if a differentiation could be made between the nucleus and 
nucleolus.   
Figure 7. SCCA carried out on simulated data sets containing added polystyrene, RN
component spectra. In each instance
was cross correlated against each data set to investigate the 
solid line shows the idealised response
Single Cell Data –SCCA 
SCCA was used to screen the Raman data set for the presence of polystyrene, RNA and lipid 
distributions. The spectra and correlation maps are shown in Figure 8. In figure 8A
of polystyrene is shown in red and the corresponding correlation map is shown adjacent
thresholded (right) and non-thresholded 
polystyrene nanoparticles in the Raman map. Importantly
from the simulated data, or more simply from a cross
with the raw average cellular spectrum,
, a pure component spectrum of polystyrene, RNA and lip
performance of the technique. The 
.  
(left) datasets. This map shows the distribution of 
, the threshold which was predicted 
-correlation of the component spectrum 
 was applied to the data set and returned a map which 
 
A and lipid 
id 
, the spectrum 
 for both 
corresponded to the previously observed Raman image from the unsupervised CLSA (Fig 4A). 
Notably, however, the spectrum is the pure spectrum of polystyrene, rather than a 
cellular/polystyrene mixture. This result shows the capability for a supervised approach for the 
unambiguous identification of polystyrene nanoparticles in complex Raman spectroscopic data 
sets. 
 Furthermore, to investigate how SCCA can be used to probe the local cellular 
environment, the lipid spectrum was used to screen the data set (Fig 8B). Again applying a 
threshold to the data set it is possible to identify regions of the cell which contain a high density 
of lipids using a supervised approach to Raman analysis. Thus it is possible to investigate the 
local cell environment to which the nanoparticles are trafficked after 24hrs. This is consistent 
with the previous K-means cluster analysis 39 which suggests that indeed the nanoparticles are 
located in a highly lipid rich environment.  
 As an additional demonstration of the potential of SCCA, a pure RNA spectrum was 
cross correlated against the data set to see if it was possible to differentiate spectra which 
corresponded to the nucleolus of the cell and thus differentiate between DNA and RNA rich 
regions of the cell. Figure 8C shows that it is possible to identify the nucleolus of the cell using 
cross correlation analysis. It was also observed that a high correlation coefficient was present in 
regions outside the nucleus. This could possibly correspond to cytoplasmic ribosomal RNA 
(rRNA) or cytoplasmic messenger RNA (mRNA). Thus a novel approach for extracting complex 
spectral information from Raman data sets is demonstrated in SCCA.    
 
Figure 8: SCCA analysis using component spectra of polystyrene (A)
ethanolamine (B) and RNA (C). The spectrum of each pure component is shown on the left of 
the figure and the correlation map
the right.   
 
Discussion  
Raman spectroscopy is a powerful tool for the investigation of biological samples. Previous 
studies have shown the capability of the technique to investigate sub cellular structures and 
processes which provide Raman images comparable to images observed usi
, 3
s for non-thresholded shown in the middle and thresholded on 
ng wide
 
-sn-phosphatidyl 
-field and 
confocal fluorescent microscopy45,46,35,39,47. Notably, however, Raman spectroscopy is a label 
free method which provides a visualization of the biochemical make up of a cell without costly 
and time consuming processing with reagents, and when combined with appropriate analysis 
methods can provide a wealth of information pertaining to biological processes in the cell. The 
aim of this paper was thus to investigate two analytical approaches both in an unsupervised and 
supervised approach and assess their ability to identify polystyrene nanoparticles and 
biochemical distributions in a single cell Raman map.  
Unsupervised CLS analysis is demonstrated to be capable of identifying the presence of 
nanoparticles in regions of the cell. However, while this method is valuable for identifying 
distributions in the cell, the model spectra generated in this manner must be further analysed to 
extract any real biochemical information. Therefore, while the analysis of the simulated dataset 
in figure 2 indicates that the unsupervised model has a higher accuracy, the model spectra 
yielded by the unsupervised CLS analysis do not directly compare to the pure component spectra 
shown in Figure 1 and therefore cannot be used to unambiguously identify the contributing 
components.  
 In contrast, employing supervised approaches to the analysis of Raman data sets allows 
for the spectral array to be screened directly with the nanoparticle or pure biochemical 
component spectrum of interest. Analysis in this way enables a direct screening of the cellular 
distribution of a particular component while simultaneously probing the chemical or biochemical 
environment of the particular location in the cell. CLSA and SCCA are both used in a supervised 
approach for analysing Raman cellular data sets (Figure 6 and Figure 8). However, 
unthresholded, both show a degree of error for all three components tested (nano-polystyrene, 
RNA and Lipids).  To correct for this, a threshold can be applied to both CLSA and SCCA. 
Importantly, this threshold should not be applied in an arbitrary manner, as this facilitates a loss 
of information from the dataset. While thresholding for supervised CLSA is arbitrary and 
subjective, the simulated datasets generated for SCCA provided a good estimation of where this 
thresholding should take place and in combination with cellular data containing no nanoparticles 
it was possible to accurately reveal where the nanoparticles were located in the cell. It should be 
noted that the thresholding level appears to be dependent on the spectral profile of the individual 
component, as it is dependent on the degree of similarity of the spectrum of the target component 
with that of the environment. Incorrect correction of spectral background may also add to the 
threshold. On the other hand the simulated data for supervised CLSA did not provide a threshold 
value to apply to the dataset and thus was arbitrarily thresholded, which is far from ideal to gain 
any reliable information about the dataset. Therefore, SCCA provides a more reliable supervised 
approach for identification of nanoparticles and other biological components when used in 
combination with a threshold generated by simulated datasets.  In addition, quantitative 
information can be extracted from the simulated data sets, with each of the three approaches 
showing some level of quantification based on how well the matched the predicted response, 
with SCCA showing the highest level of sensitivity of the three techniques. SCCA is specifically 
a supervised approach, as it is necessary to provide the pure component spectrum. However, it is 
conceivable the technique could be extended to a library of reference spectra which could in turn 
be screened against the data set in an unsupervised manner. 
 
Conclusions 
CLSA and SCCA are shown to be two methods capable of identifying intracellular polystyrene 
nanoparticles and also to probe the local biochemical environment the nanoparticles are 
trafficked to within the cell. CLSA is a relatively straight forward method for analysing 
spectroscopy data sets. However, SCCA is demonstrated in the simulated data sets to be a more 
sensitive approach for nanoparticle identification. It is envisaged that both these and other 
supervised methods will provide analytical approaches which can be used not only as 
identification methods for other nanoparticles inside cells and detection of resultant biochemical 
changes, but also to provide alternate analytical approaches to the study of other processes such 
as chemotherapeutic response of cells to drugs. Additionally the full quantitative nature of these 
analytical approaches will need to be explored if Raman spectroscopy is to become a routine 
application in the study of nano-bio interactions and beyond.   
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